By Drug Target Review2025-03-17T09:00:53
Scientists at the University of Virginia (UVA) School of Medicine have uncovered a crucial mechanism behind the lingering effects of long COVID, revealing how severe COVID-19 infections impair immune cells’ ability to repair lung tissue.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-05-10T11:18:16
Sponsored by Revvity
2023-11-20T13:43:43
Sponsored by Merck
2024-05-10T11:23:31
Sponsored by BellBrook Labs
Site powered by Webvision Cloud